A simple blood draw could spot prostate cancer early
NCT ID NCT04556916
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study investigates whether a blood test (liquid biopsy) can detect prostate cancer early by looking for tumor cells and genetic material in the blood. Researchers will compare blood samples from men with suspected prostate cancer to those without the disease. The goal is to find a reliable, non-invasive way to identify aggressive cancers and reduce unnecessary biopsies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Blood sample analysis for circulating tumor cells, DNA, and exosomes
What this could lead to
If successful, this could lead to a simple blood test that detects prostate cancer earlier and more accurately than current methods, potentially reducing unnecessary biopsies.
What could go wrong
This is an early-stage study with 320 participants, so the test may not prove accurate enough for widespread use. The results need validation in larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Montpellier - Département d'urologie et transplantation rénale
RECRUITINGMontpellier, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Montpellier - Laboratoire des Cellules Circulantes Rares Humaines
ACTIVE_NOT_RECRUITINGMontpellier, France
-
CHU de Nîmes - Service Urologie Andrologie Sexologie
RECRUITINGNîmes, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Clinique Beau Soleil - Service d'urologie
RECRUITINGMontpellier, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••